determine the maximum technical and economic capacity and shortest times that would be possible to scale up production and supplies of different methods of testing. (5) Determination of infection rates The Director shall implement an emergency serologic testing program in at least two distinct geographic areas of high infection rates to help determine levels of infection relative to levels of those with symptoms, those hospitalized, and those in need of intensive care. (6) Use of tests in reopening plans The Director shall evaluate the potential and logistics of different forms of testing, including mobile testing units, using different products as appropriate, to contribute to reopening plans. Possible ways of using testing to be evaluated shall include using different forms of tests as a way to filter those available for employment or eligible to engage on other social activities, use of tests for contact tracing and quarantine, use of tests for particular categories of high-contact employment, and use of population-level testing. Based on these analyses and the best available information regarding sources and levels of disease transmission, the Director shall provide as soon as possible recommendations for how different forms of testing under different requirements might be capable of contributing to reopening plans and shall update these recommendations as new information becomes available. (7) Assistance by government All Federal departments and agencies shall make available on an emergency basis any requested or useful information to the Director and to the Coronavirus Testing Advisory Panel for carrying out this section. (c) Authorization For the period beginning on the date of enactment of this Act and ending at the end of fiscal year 2021, the Director may expend such funds, without further appropriation, as necessary as determined by the Director for carrying out this section. 7. Coronavirus Reopening Advisory Panel (a) In general Within 10 business days of the date of enactment of this Act, the